Krystexxa - pegloticase
Navigation: NDC > Supplier starting with: S > SAVIENT PHARMACEUTICALS, INC.| Field | Value |
|---|---|
| NDC Code: | 54396-801 |
| Proprietary Name: | Krystexxa |
| Suffix: | |
| Non-Proprietary Name: | pegloticase |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 14-09-2010 |
| Category Name: | BLA |
| Application Number: | BLA125293 |
| Labeler: | SAVIENT PHARMACEUTICALS, INC. |
| Substance Name: | PEGLOTICASE |
| Active Numerator Strength: | 8 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC] |
| DEA Schedule: |